Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2000
10/31/2000US6140093 Nucleotide sequences coding an enzymatic protein for use as an antidote in organophorphous insecticide poisoning and to prevent neuronal cell
10/31/2000US6140089 Jacket confined viable aggregations; for maintaining, propagating, proliferating, and differentiating viable cells trapped between the chitin polysaccharide matrix
10/31/2000US6140085 Genetic control of flowering
10/31/2000US6140072 Functional recombinantly prepared synthetic protein polymer
10/31/2000US6140039 Comprising fibroblasts and collagen naturally secreted by the fibroblasts attached to and substantially enveloping a three-dimensional filamentous framework composed of a biocompatible, non-living material having interstitial spaces
10/31/2000US6139869 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
10/31/2000US6139846 Protein D- an IGD-binding protein of haemophilus influenzae
10/31/2000US6139835 Homologous recombination for allogeneic donor cells
10/31/2000CA2185112C Humanized monoclonal antibodies against human interleukin-4
10/31/2000CA2081885C Increased starch content in plants
10/31/2000CA2009403C A packaging defective hiv provirus, cell lines, and uses thereof
10/31/2000CA1341131C Human nerve growth factor
10/27/2000CA2307108A1 Process for production of mammalian cell lines, produced cell lines and their uses
10/27/2000CA2307104A1 Human myoblast cell lines and their uses
10/26/2000WO2000063690A1 Enriched antigen-specific t-cells, and related therapeutic and prophylactic compositions and methods
10/26/2000WO2000063667A2 Methods for identifying modulators of n-type ion channel inactivation
10/26/2000WO2000063438A2 Method of classifying a thyroid carcinoma using differential gene expression
10/26/2000WO2000063435A2 Method of identifying toxic agents using differential gene expression
10/26/2000WO2000063434A1 MinK-RELATED GENES, FORMATION OF POTASSIUM CHANNELS AND ASSOCIATION WITH CARDIAC ARRHYTHMIA
10/26/2000WO2000063425A2 Compound assay using nematodes
10/26/2000WO2000063415A1 Dna encoding the human vanilloid receptor vr1
10/26/2000WO2000063410A1 Methods and compositions for transforming cells using site-specific recombination
10/26/2000WO2000063403A2 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein
10/26/2000WO2000063398A1 Plant transformation method
10/26/2000WO2000063396A1 Method for enhancing myoblast migration and invasion in the context of gene therapy
10/26/2000WO2000063395A1 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
10/26/2000WO2000063393A1 Dsp-8 dual-specificity map kinase phosphatase
10/26/2000WO2000063391A2 Nucleic acid sequences to proteins involved in tocopherol synthesis
10/26/2000WO2000063389A1 Nucleic acid sequences to proteins involved in isoprenoid synthesis
10/26/2000WO2000063382A1 Genes and expression products from hematopoietic cells
10/26/2000WO2000063380A1 Vascular endothelial cell growth factor variants and uses thereof
10/26/2000WO2000063379A2 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
10/26/2000WO2000063378A2 Zalpha13: a human secreted protein
10/26/2000WO2000063377A1 Adipocyte complement related protein homolog zacrp3
10/26/2000WO2000063376A1 Adipocyte complement related protein homolog zacrp2
10/26/2000WO2000063374A1 Synthetic transmembrane components
10/26/2000WO2000063372A1 Synthetic signalling molecules
10/26/2000WO2000063371A1 Protease activated receptor 2 variants
10/26/2000WO2000063370A2 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000WO2000063368A1 Recombinant protein uk114 and its use in therapy and diagnostics
10/26/2000WO2000063367A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
10/26/2000WO2000063360A1 Combinatorial method for producing nucleic acids
10/26/2000WO2000063358A1 Noninvasive detection of colorectal cancer and other gastrointestinal pathology
10/26/2000WO2000063352A2 Human homologues of fused gene
10/26/2000WO2000063351A2 Carbohydrate-modifying enzymes
10/26/2000WO2000063348A2 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
10/26/2000WO2000063268A1 Poly(propylene fumarate) cross linked with poly(ethylene glycol)
10/26/2000WO2000063263A1 Biodegradable poly(propylene fumarate) networks cross linked with poly(propylene fumarate)-diacrylate macromers
10/26/2000WO2000063251A1 Composition and method for modulating dendritic cell-t cell interaction
10/26/2000WO2000063247A2 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000WO2000063241A2 Methods and compositions for modulating an immune response
10/26/2000WO2000063236A2 Adhesion modulatory peptides and methods for use
10/26/2000WO2000063230A2 49 human secreted proteins
10/26/2000WO2000063221A2 Galectin 11
10/26/2000WO2000062862A1 Method of prophylaxis and treatment of diabetes
10/26/2000WO2000062833A1 Cellular matrix system and use thereof
10/26/2000WO2000062828A1 Autologous fibrin sealant and method for making the same
10/26/2000WO2000062818A1 Differentiation of monocytes into functional dendritic cells
10/26/2000WO2000062804A2 Identification of sortase gene
10/26/2000WO2000062787A1 Methods and compositions for use in potentiating antigen presentation by antigen presenting cells
10/26/2000WO2000062736A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/26/2000WO2000062630A1 Functionalized poly(propylene fumarate) and poly(propylene fumarate-co-ethylene glycol)
10/26/2000WO2000039275A3 Multiple shear stress responsive elements (ssre) and methods of use thereof
10/26/2000WO2000037646A3 Group b streptococcus proteins, and their use
10/26/2000WO2000036143A3 Selecting animals for parentally imprinted traits
10/26/2000WO2000036135A3 Screening methods based on the use of protein kinases
10/26/2000WO2000036108A3 Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides
10/26/2000WO2000036089A3 Methods of immunosuppression
10/26/2000WO2000034449A3 UDP-N- ACETYL GLUCOSAMINE: GALACTOSE-β1, 3-N- ACETYL GALACTOSAMINE- α-R/ N- ACETYL GLUCOSAMINE -β1, 3-N- ACETYL GALACTOSAMINE- α-R (GlcNAc TO GalNAc) β1,6-N- ACETYL GLUCOSAMINYL TRANSFERASE, C2/4GnT
10/26/2000WO2000034294A3 Tumor necrosis factor receptor homologue-1 ('trh1')
10/26/2000WO2000029586B1 Maize dna ligase i orthologue and uses thereof
10/26/2000WO2000028045A3 Human hydrolase proteins
10/26/2000WO2000028000A3 Method for producing dendritic cells
10/26/2000WO2000026391A3 Trans-species transfer of apoptotic genes and transgenic plants developed thereby
10/26/2000WO2000025808A8 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists
10/26/2000WO2000024770A9 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
10/26/2000WO2000023806A9 Detection and quantification of vancomycin in biological fluids
10/26/2000WO2000020601A3 Polyketide synthase enzymes and recombinant dna constructs therefor
10/26/2000DE19918365A1 New nucleic acid encoding flavone synthase II, useful e.g. for producing transgenic plants with altered flower color or flavone content
10/26/2000DE19918327A1 Generating donor tolerance in humans, useful for inducing compatibility with xenotransplants, comprises injection of fetus or embryo with donor stem cells
10/26/2000DE19917532A1 Carrier-bound keratinocyte stem or precursor cells, useful for cosmetic or therapeutic regeneration of the epidermis
10/26/2000CA2373359A1 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000CA2371976A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
10/26/2000CA2371611A1 Galectin 11
10/26/2000CA2370945A1 Method of classifying a thyroid carcinoma using differential gene expression
10/26/2000CA2370659A1 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
10/26/2000CA2370617A1 Dsp-8 dual-specificity map kinase phosphatase
10/26/2000CA2370616A1 Nucleic acid sequences to proteins involved in isoprenoid synthesis
10/26/2000CA2370615A1 Methods for identifying modulators of n-type ion channel inactivation
10/26/2000CA2370609A1 Adipocyte complement related protein homolog zacrp3
10/26/2000CA2370602A1 Adipocyte complement related protein homolog zacrp2
10/26/2000CA2370570A1 Dna encoding the human vanilloid receptor vr1
10/26/2000CA2370301A1 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000CA2370272A1 Protease activated receptor 2 variants
10/26/2000CA2370246A1 Vascular endothelial cell growth factor variants and uses thereof
10/26/2000CA2370144A1 Noninvasive detection of colorectal cancer and other gastrointestinal pathology
10/26/2000CA2370142A1 Recombinant protein uk114 and its use in therapy and diagnostics
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
10/26/2000CA2369969A1 Method of identifying toxic agents using differential gene expression
10/26/2000CA2369844A1 Nucleic acid sequences to proteins involved in tocopherol synthesis
1 ... 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 ... 1827